Induction of nerve growth factor by butanol fraction of Liriope platyphylla in C6 and primary astrocyte cells

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 8, 2004, Pages 1257-1260

  Hur, Jinyoung ^a   Lee, Pyeongjae ^b   Kim, Jeongmin ^a   Kim, Ae Jung ^c   Kim, Hocheol ^a   Kim, Sun Yeou ^a  

^a Kyung Hee University   (South Korea)

^b National Institute of Animal Science   (South Korea)

^c Hyejeon University   (South Korea)

Author keywords

Astrocyte; Liriope platyphylla; Nerve growth factor; Neurite outgrowth; PC12

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; BUTANOL; LIRIOPE PLATYPHYLLA EXTRACT; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR ANTIBODY; PLANT EXTRACT; PROTEIN KINASE C INHIBITOR; UNCLASSIFIED DRUG; BISINDOLYLMALEIMIDE I; INDOLE DERIVATIVE; MALEIMIDE DERIVATIVE; PRIMER DNA;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL LINE; CONTROLLED STUDY; LIRIOPE PLATYPHYLLA; MEDICINAL PLANT; NERVE FIBER GROWTH; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SECRETION; RAT; ANIMAL; BIOSYNTHESIS; CHEMISTRY; CULTURE MEDIUM; DRUG EFFECT; LIRIOPE (PLANT); METABOLISM; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ASTROCYTES; BASE SEQUENCE; BUTANOLS; CELL LINE; CULTURE MEDIA, CONDITIONED; DNA PRIMERS; INDOLES; LIRIOPE PLANT; MALEIMIDES; NERVE GROWTH FACTOR; PLANT EXTRACTS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 16644362452     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.1257     Document Type: Article

References (24)

1. Barres B. A., Barde Y., Curr. Opin. Neurobiol., 10, 64-68 (2000).
2. Levi-Montalcini R., EMBO J., 6, 1145-1154 (1987).
3. Pesavento E., Capsoni S., Domenici L., Cattaneo A., Eur. J. Neurosci., 15, 1030-1036 (2002).
4. Brinton R. D., Yamazaki R. S., Pharm. Res., 15, 386-398 (1998).
5. Jehan F., Neveu I., Phillippe N., Naveihan P., Wion D., Brachest P., Brain Res., 672, 128-136 (1995).
6. Baek N., Cho S. J., Agri. Chem. Biotec., 41, 390-394 (1998).
7. Kim S. W., Chang I. M., Oh K. B., Biosci. Biotechnol. Biochem., 66, 2751-2754 (2002).
8. Greene L. A., Tischler A. S., Proc. Natl. Acad. Sci. U.S.A., 73, 2424-2428 (1976).
9. Lee D. Y., Son K. H., Do J. C., Kang S. S., Arch. Pharm. Res., 12, 295-299 (1989).
10. Obara Y., Nakahata N., Kita T., Takaya Y., Kobayashi H., Hosoi S., Kiuchi F., Ohta T., Oshima Y., Ohizumi Y., Eur. J. Pharmacol., 370, 79-84 (1999).
11. Hur J. Y., Soh Y., Kim B. H., Suk K., Sohn N. W., Kim H. C., Kwon H. C., Lee K. R., Kim S. Y., Biol. Pharm. Bull., 24, 921-924 (2001).
12. Kwon H. C., Jung I. Y., Cho S. Y., Cho O. R., Yang M. C., Lee S. O., Hur J. Y., Kim S.Y., Yang J. B., Lee K. R., Arch. Pharm. Res., 26, 471-477 (2003).
13. Levi A., Biocca S., Cattaneo A., Calissano P., Mol. Neurobiol., 2, 201-226 (1988).
14. Yutaro O., Norimichi N., Drug News Perspect., 15, 290-298 (2002).
15. Pshenichkin S. P., Szekely A. M., Wise B. C., J. Neurochem., 63, 419-428 (1994).
16. Belliveau D. J., Krivko I., Kohn J., Lachance C., Pozniak C., Rusakov D., Kaplan D., Miller F. D., J. Cell Biol., 136, 375-388 (1997).
17. Satoh T., Nakamura S., Taga T., Hirano T., Kishimoto T., Aziro Y., Mol. Cell. Biol., 8, 1145-1150 (1988).
18. Whitehouse P., Price D., Struble R., Clarke A., Coyle J., Delong M., Science, 215, 1237-1239 (1982).
19. Olson L., Exp. Neurol., 124, 5-15 (1993).
20. Saporito M. S., Carswell S., J. Neurosci., 15 (3 Pt 2), 2280-2286 (1995).
21. Salim K. N., McEwen B. S., Chao H. M., Brain Res. Mol. Brain Res., 47, 177-182 (1997).
22. Lee D. R., Sawada M., Nakano K., Neurosci. Lett., 244, 17-20 (1998).
23. Ohta K., Ohta M., Mizuta I., Fujinami A., Shimazu S., Sato N., Yoneda F., Hayashi K., Kuno S., Neurosci. Lett., 328, 205-208 (2002).
24. Fukumoto H., Kakihana M., Suno M., Glia, 12, 151-160 (1994).